Related Experiment Videos
Vancomycin-induced thrombocytopenia: a challenge and rechallenge
C E Howard1, L A Adams, J L Admire
1McWhorter School of Pharmacy, Samford University, Birmingham, AL 35229, USA.
The Annals of Pharmacotherapy
|March 1, 1997
Summary
Vancomycin, an antibiotic, can rarely cause thrombocytopenia (low platelet count). This case highlights a patient whose platelet levels dropped significantly during vancomycin treatment, improving after discontinuation.
Area of Science:
- Pharmacology
- Hematology
- Infectious Diseases
Background:
- Vancomycin is a critical antibiotic for treating serious Gram-positive bacterial infections, including methicillin-resistant Staphylococcus aureus (MRSA).
- Thrombocytopenia, a condition characterized by abnormally low platelet counts, can arise from various causes, including adverse drug reactions.
Observation:
- A 58-year-old male patient with chronic osteomyelitis experienced recurrent, severe thrombocytopenia during two separate courses of vancomycin therapy.
- The patient's platelet count decreased dramatically during vancomycin administration and recovered promptly upon drug cessation, suggesting a causal relationship.
Findings:
- Bone marrow examination revealed an increased number of megakaryocytes, indicating the body's attempt to compensate for platelet destruction.
- The observed pattern strongly implicates vancomycin as the likely cause of drug-induced thrombocytopenia in this patient.
Implications:
- This case underscores the importance of monitoring platelet counts in patients receiving vancomycin, especially those with prolonged treatment durations.
- Understanding the potential mechanisms of vancomycin-induced thrombocytopenia (direct toxicity, hapten formation, immune response) is crucial for clinical management and patient safety.